Joseph Caprini/LinkedIn
Nov 15, 2025, 08:19
Joseph Caprini Released His UIP 2025 Session on VTE Recurrence Risk
Joseph Caprini, Senior Clinician Educator at The University of Chicago Pritzker School of Medicine, shared on LinkedIn:
”Just released my UIP 2025 session with Alfonso J. Tafur MD MS MBA RPVI on measuring VTE recurrence risk and tailoring treatment.
Dr. Caprini discusses how to pinpoint patients at greatest risk of VTE recurrence and highlights the value of the Caprini Risk Score in guiding long-term prevention.
He also explains how biomarkers, imaging, clinical history, and practical decision frameworks support more precise assessments and determine when extended prophylaxis is warranted.
Stay updated with Hemostasis Today.
-
May 27, 2026, 04:47Daniel Torrent: The Overlooked Epidemic of Post-Thrombotic Syndrome
-
May 27, 2026, 04:45Graziella Pompei: Is Aspirin Still a Valid Alternative to Clopidogrel in PCI with DES Implantation?
-
May 27, 2026, 04:40Kausik Ray: Phase 1 Trial Highlights Anti-Inflammatory Effects of Ruvonoflast
-
May 27, 2026, 04:29Francisco Chacón-Lozsán: High-Sensitivity Troponin and the Evolving Management of NSTEMI
-
May 27, 2026, 04:14Michael R. Jaff: HI-PEITHO Trial and NEWS Score Insights on Advances for Intermediate-Risk Pulmonary Embolism
-
May 26, 2026, 16:45Ashley George: Take the Leap for Thrombosis UK
-
May 26, 2026, 16:40Hamed Helisaz: Machine Learning for Detecting Missing Heart Medications
-
May 26, 2026, 15:32Haroun Gajraj: Brown Marks After Microsclerotherapy – What Every Practitioner Needs to Know
-
May 26, 2026, 15:29Jacqueline van Paassen: Lack of Essential Clinical Data in DOAC Prescriptions in Community Pharmacies